Methylglyoxal impairs β-adrenergic signalling in primary rat adipocytes

Tomasz Szkudelski1, Aleksandra Cieślewicz1, Katarzyna Szkudelska1

  • 1Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland.

Insights

Methylglyoxal (MG) impairs fat breakdown (lipolysis) in rat fat cells by interfering with epinephrine signaling. This finding suggests a novel mechanism linking MG to metabolic dysfunction.

Area of Science:

  • Metabolic biochemistry
  • Cellular metabolism
  • Endocrinology

Background:

  • Methylglyoxal (MG) is a reactive dicarbonyl compound formed from glucose metabolism.
  • Elevated MG levels are linked to various pathological conditions.
  • Understanding MG's cellular effects is crucial for metabolic disease research.

Purpose of the Study:

  • To investigate the short-term metabolic effects of methylglyoxal (MG) on isolated rat adipocytes.
  • To determine MG's impact on insulin-stimulated lipogenesis and epinephrine-stimulated lipolysis.
  • To elucidate the signaling pathways affected by MG in adipocytes.

Main Methods:

  • Isolated rat adipocytes were treated with varying concentrations of methylglyoxal (MG).
  • Lipogenesis was assessed by measuring insulin-induced lipid synthesis.
  • Lipolysis was measured by quantifying glycerol release following stimulation with epinephrine or other signaling agents.
  • Specific signaling pathway activators (forskolin, dibutyryl-cAMP) and receptor antagonists were used.

Main Results:

  • Methylglyoxal (MG) did not alter insulin-induced lipogenesis.
  • Epinephrine-stimulated lipolysis was significantly inhibited by MG (200 µM) in adipocytes.
  • MG's inhibitory effect on lipolysis was independent of glucose or alanine presence.
  • MG did not affect lipolysis induced by forskolin, dibutyryl-cAMP, or DPCPX, indicating the effect is upstream of adenylate cyclase and PKA.
  • Pre-incubation with MG followed by epinephrine stimulation also showed unchanged lipolysis, suggesting a direct interaction with epinephrine or its receptor.

Conclusions:

  • Methylglyoxal (MG) significantly impairs epinephrine-stimulated lipolysis in rat adipocytes.
  • The data suggest MG interferes with beta-adrenergic signaling, potentially by interacting with epinephrine itself.
  • These findings highlight a novel mechanism by which MG may disrupt adipocyte function and contribute to metabolic disturbances.